<DOC>
	<DOCNO>NCT01832181</DOCNO>
	<brief_summary>The prevalence diabetes pregnancy rise maternal age group . There increase evidence in-utero exposure maternal diabetes associate increase risk obesity type 2 diabetes child adult . There urgent need reduce increase rate obesity diabetes subsequent generation . The MiTy Trial ( Metformin Women Type 2 Diabetes Pregnancy Trial ) CIHR-funded multi-centre , randomize control trial woman type 2 diabetes pregnancy ( sample size n=500 ) . The MiTy Trial look determine effect addition metformin standard regimen insulin woman diabetes , perinatal morbidity mortality . The MiTy Kids Trial follow-up MiTy Trial determine whether treatment metformin pregnancy woman type 2 diabetes lead reduction adiposity improvement insulin resistance offspring woman diabetes 2 year age .</brief_summary>
	<brief_title>MiTy Kids ( Metformin Women With Type 2 Diabetes Pregnancy Kids Trial )</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Pregnancy Diabetics</mesh_term>
	<mesh_term>Diabetes , Gestational</mesh_term>
	<mesh_term>Metformin</mesh_term>
	<criteria>Offspring woman type 2 diabetes participate ( participate ) MiTy trial . Offspring major congenital anomaly .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Diabetes</keyword>
	<keyword>MiTy</keyword>
	<keyword>Metformin Women</keyword>
	<keyword>Type 2 Diabetes Pregnancy</keyword>
</DOC>